In this context, given the role of ERAP enzymes in the regulation of RAS, hypertension, antigen processing, inflammatory disorders, and cytokines and NO release, we hypothesize that knowledge of ERAP1 and ERAP2 genotypes may be useful in identifying the appropriate therapy for each COVID-19 patient. The gene discussed is ERAP2; the disease is COVID-19.